Bias does not equal bias by Baumgartner, Renate & Kuhn, Sarah
www.ssoar.info
Bias does not equal bias
Baumgartner, Renate; Kuhn, Sarah
Veröffentlichungsversion / Published Version
Zeitschriftenartikel / journal article
Empfohlene Zitierung / Suggested Citation:
Baumgartner, R., & Kuhn, S. (2021). Bias does not equal bias. TATuP - Zeitschrift für Technikfolgenabschätzung
in Theorie und Praxis / Journal for Technology Assessment in Theory and Practice, 30(2), 69-70. https://
doi.org/10.14512/tatup.30.2.69
Nutzungsbedingungen:
Dieser Text wird unter einer CC BY Lizenz (Namensnennung) zur




This document is made available under a CC BY Licence
(Attribution). For more Information see:
https://creativecommons.org/licenses/by/4.0
Diese Version ist zitierbar unter / This version is citable under:
https://nbn-resolving.org/urn:nbn:de:0168-ssoar-74375-2
MEETING REPORT
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schweig & Hochschule Emden Leer) spoke about a framework 
for examining AI‑based health apps for diagnosis. They will use 
feminist concepts of agency from Science and Technology Stud‑
ies (STS) as framework in their upcoming ethnographic study 
on classifications and biases in data. K. Napiwodzka and K. Ci‑
erszko (Adam Mickiewicz University, Poznań) asked whether AI 
could provide a safe space for female body politics in the highly 
contested political environment in Poland. P. Martin and J. Ding 
(University of Sheffield) presented the repurposing of common 
drugs for the treatment of rare diseases as a possible use of AI 
in medical research. The assistance of AI could accelerate and 
economize the approval process and improve access to therapy. 
W. Ernst (Johannes Kepler University, Linz) asked if standards 
of medical research can be questioned with AI and pointed out 
issues such as: Who can be the representative of who’s body? 
How are categories envisioned? And to whose benefit?
Fairness and diversity in medical AI.  C. Kropp and K. Tampe‑ 
Mai (University of Stuttgart) considered ‘accessibility’ as a 
crucial point for social in/justice in AI based smart healthcare 
systems. The constraints to be considered are financial access, 
 usability and digital health literacy. S. Morais dos Santos Bruss 
(TU Dresden) used a feminist‑decolonial perspective to explore 
“surrogate”‑robotics and the care‑revolution. H. Drukarch (Lei‑
den University) showed how a lack of diversity for AI in medi‑
cine means erasure, exclusion and silencing of minorities. How‑
ever, data can also construct (new) normalities when presented 
as facts and reproduce and naturalize social categories.
Postcolonial perspectives.   K. Vlantoni and K. Papanastasiou 
(National and Kapodistrian University of Athens) analyzed ex‑
pectations concerning the integration of medical AI in Greece 
against the background of technological enthusiasm and national‑
ism. S. Mbelu (Erasmus University Rotterdam) reflected on how 
to design and provide AI enabled health insurance platforms in 
Nigeria without the pitfalls the Global North has experienced. 
He concluded that new technologies may have the potential to 
add important value, e. g. for healthcare universalism, but also 
exacerbate health disparities to the detriment of the most vul‑
nerable. With the example of Native American Tribes, T. Hendl 
and T. Roxanne (LMU Munich) pointed out risks of using digi‑
tal surveillance for racialized minorities during the COVID‑19 
pandemic. They argued for the inclusion of and respect for in‑
digenous perspectives and indigenous data sovereignty.
Discourses and knowledge production.   The third day of the 
conference started with K. Wiggert’s (TU Berlin) study on da‑
ta‑driven clinical decision support systems for cardiology‑re‑
lated diseases that allow physicians to simulate effects of dif‑
ferent treatment strategies. The tools reshape medical reasoning 
and decision‑making. However, physicians who were involved in 
the process ultimately did not feel represented by the tool. Col‑
laborations between engineers and physicians throughout the de‑
velopment process thus should be based on the needs of physi‑
OPEN   ACCESS
The interdisciplinary conference Fair medicine and artificial 
intelligence was held at the Center for Gender and Diversity 
Research, University of Tübingen, from 3–5 March. About 70 
participants from the social sciences, philosophy, and medical 
ethics developed socio‑technical perspectives on artificial in‑
telligence (AI) and machine based applications as well as deep 
learning technologies in the medical and healthcare sectors. The 
big promises for possible future applications of AI in the pro‑
fessional medical field, e. g. diagnosis, prognosis, and therapy 
recommendations, lead to assumptions that AI will soon play 
an important role in the health sector and will help to address 
healthcare disparities, which are currently posing an individ‑
ual threat, a threat to social justice and a major challenge to the 
healthcare system. AI could, for instance, reveal human bias, 
provide more equal treatment to all patients, make health care 
more accessible and identify possibilities of improvement to de‑
velop a more just healthcare system. However, critical voices 
warn that AI might heighten existing inequalities as technical 
complexities make them harder to detect.
Socio-technical perspectives
Future applications of AI.  E. Detfurth (York University) talked 
about AI data‑driven applications for dementia care. She showed 
how classification systems of data repositories and brain atlases 
find their way into AI tools and described chances and limitations 
of AI‑assisted dementia diagnosis. A. K. Kühnen (TU Dresden) 
focused on the question of representation of BIPOC, conclud‑
ing that AI might reproduce and exacerbate inequalities between 
“white” and non‑white racial groups. When analyzing racial bias, 
technological as well as economic, historical and biopolitical as‑
pects need to be considered. C. Bath and S. Samerski (TU Braun‑
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nist STS and user‑driven approaches to 
develop non‑biased AI. She furthermore 
suggested starting the development pro‑
cess with the definition of a problem that 
needs to be solved and not with imagin‑
ing users, because the later step is prone 
to mistakes.
In the second keynote, K.  Ferryman 
(New York University, Tandon School 
of Engineering) presented the Fairness 
in precision medicine project which uses 
critical medical anthropology and a STS 
approach to take on the task to center 
health equity in precision medicine. She 
also showed how being included in data 
is important and at the same time a pri‑
vacy and security risk.
Lessons learned and outlook
In her summary discussion R. Ammicht‑Quinn, director of the 
hosting center, pointed to topics and questions that kept resurfac‑
ing during the conference, in particular issues of categorization, 
objectification and representation in different health contexts 
and technologies. Which categorizations are at work and how do 
they work? Are categorizations a form of objectification? Who 
can represent (and be representative of) whose body, who is rel‑
evant for a specific representation and who counts as standard?
Throughout the conference biases in medical AI had been 
a focal point on different levels. The question “how does fair‑
ness relate to the most desirable bias?” remains – even if we ac‑
cept that nothing is without bias. Several speakers talked about 
diversity in all its ambivalences. How is it possible to avoid 
erasure, exclusion and silencing? How do we deal with the di‑
lemma of either seeking participation or valuing patients’ pri‑
vacy? The benefits of health AI to facilitate development of 
treatment of rare diseases was one of the few examples that fo‑
cused on chances and advantages of AI in medicine. Through 
the vast majority of topics, the critical analysis of AI pervaded 
the talks. This seemingly huge gap between the promotion of 
benefits and fundamental critique was also addressed in both 
keynotes. AI holds the potential to facilitate and accelerate pro‑
cesses within medicine and healthcare to promote health for all. 
At the same time, we must be wary of whose values and which 
knowledge are inscribed in data and technique during the devel‑
opment processes.
cians and not only on the ideas of engineers, to improve this as‑
pect. V. Galanos (The University of Edinburgh) opened with an 
assessment of the discrepancy between AI in public discourses 
and research. He explored the balance between the accuracy 
and instability of AI in radiology and proposed the inclusion 
of contextual reasoning in the development of AI to avoid pit‑
falls. R. Baumgartner (University of Tübingen) proposed to take 
on the goal of “health equity” over “fairness” and laid out one 
of the key challenges in reaching health equity through AI, the 
“participation vs. privacy dilemma”, concluding that the worth 
of privacy balanced against the asset of being represented in da‑
ta‑based AI tools is more precarious for minorities than for the 
majority population.
Ethical perspectives.  C. Lenk (Ulm University) argued that col‑
lection of data variables, such as social determinants of health 
in patient data, so far is insufficient to consider healthcare in‑
equality. P. Lopez (University of Vienna) presented a new so‑
cio‑technical typology in data‑based algorithmic systems that 
distinguishes between societal, socio‑technical and technical bi‑
ases. T. Grote (University of Tübingen) talked about the norma‑
tive relevance of different accounts of algorithmic bias in med‑
ical practice. He concluded that in decision support systems, as 
opposed to automated systems, the assurance of fairness in the 
final decision is in practice more relevant than algorithmic fair‑
ness per se. The last presentation by T. Gremsl and D. Schnee‑
berger (University of Graz) combined ethical and legal perspec‑
tives while presenting interdisciplinary commentaries on the 
proposed European framework of ethical aspects of AI, robot‑
ics and related technologies.
Keynotes.  C. Bath (TU Braunschweig), in the first keynote of 
the conference, identified algorithmic bias as rooted in dis‑
criminatory beliefs of humans whose values and norms are in‑
scribed into the tools. She proposed design methods against dis‑
crimination and exclusion informed by gender studies, femi‑
Illustration 1: This picture was created by a StyleGAN neuronal network following the input of “diversity” 
training pictures extracted from Google.  Source: Timo Dufner
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